What precautions should be taken during oxygen therapy for COPD?
Patients with chronic obstructive pulmonary disease (COPD) commonly present with cough, sputum production, and dyspnea. Sputum is typically white, mucoid, or frothy and serous. When sputum volume increases significantly or becomes yellowish, a concurrent respiratory tract infection should be suspected. So, what precautions should be taken during oxygen therapy for COPD? The following section addresses this question.

What precautions should be taken during oxygen therapy for COPD?
Oxygen therapy for COPD patients must employ low-flow oxygen delivery; high-flow oxygen administration is strictly contraindicated. This is because many COPD patients experience carbon dioxide (CO2) retention, resulting in diminished central chemoreceptor sensitivity to CO2. Consequently, their respiratory drive relies primarily on stimulation of peripheral chemoreceptors by hypoxia. High-concentration oxygen therapy rapidly corrects hypoxia, thereby removing the hypoxic stimulus to peripheral chemoreceptors and potentially suppressing respiratory drive—leading to further CO2 accumulation.
The diagnosis of COPD is primarily based on pulmonary function test results. A mandatory diagnostic criterion is a post-bronchodilator forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio < 70%, indicating persistent, irreversible airflow limitation. Additionally, elevated total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV), along with reduced vital capacity (VC), provide valuable supportive evidence for COPD diagnosis.
The above outlines key considerations for oxygen therapy in COPD patients. We hope this information is helpful to you.